Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,588 total articles
Covista (CVSA) is not a headline-free rebound, but the stock now sits at a more attractive entry after a pullback and a period of consolidation. With a market cap near $4.15B, free cash flow of $336M and a P/E in the high-teens, the balance of fundamentals vs. technical risk favors a tactical long position for a position horizon (46-180 trading day…
Palantir's strong Q1 growth, exceptional margins, and strategic partnerships have turned its rich multiples from a showstopper into a calculated risk. This trade idea lays out an entry at $148.00, a stop at $119.00 and a target of $190.00 over a 180-day horizon, with catalysts and a balanced view of risks.
Legend Biotech (LEGN) is trading near $36.51 after a fresh rally tied to positive data and analyst interest. The company has commercial momentum with CARVYKTI sales and improving manufacturing scale; the trade is a momentum swing long into the 52-week high at $45.30 with a defined stop to manage biotech volatility.
Novo Nordisk is trading at roughly $43 with a market cap near $193B and a P/E of ~10. The market has punished the stock for near-term pricing and competition in GLP-1 drugs, but fundamentals - recurring revenue from diabetes and obesity care, an expanding oral Wegovy adoption, and a healthy dividend - argue for a re-rating if growth normalizes in 2…
AT&T trades at single-digit earnings multiples with a healthy free cash flow profile, a roughly 4.5% dividend yield, and a $19 billion California fiber commitment that demonstrates capital allocation toward durable growth assets. We present a long trade with disciplined risk controls that targets a meaningful multiple expansion while capturing inco…
Star Bulk (SBLK) pays a $0.50 distribution with ex-date 06/12/2026 and sits at $27.39. On a baseline interpretation that $0.50 is a quarterly payment, annualized cash could be $2.00 per share (roughly 7.3% yield). More interestingly, one scenario — monetizing asset value roughly equivalent to the $470.5M 16-vessel package discussed in recent transa…
Roku has cleared a key scale milestone - more than 100 million streaming households - and is turning that reach into accelerating platform revenue and free cash flow. The business mix is shifting from hardware to higher-margin ads and subscriptions; given improving profitability, robust FCF, and a still-conservative runway for ad monetization, I re…
Hexcel (HXL) sits at the center of a multi-decade shift toward lightweight composites across commercial aerospace, space launch vehicles, and defense platforms. With a $6.6B market cap, positive free cash flow and exposure to markets growing at ~8%+ CAGRs, HXL offers a way to play structural demand. This trade idea recommends going long with an ent…
Rocket Lab (RKLB) has posted rapid top-line growth and a backlog north of $2 billion while preparing the Neutron reusable rocket for a maiden flight by the end of 2026. At $123.31 the stock already prices a great deal of future optionality — this trade buys a defined-risk position ahead of key catalysts while acknowledging high valuation and execut…
Apple is benefitting from AI integration across its ecosystem without the heavy data-center capex that burdens other AI leaders. With recurring services growth, $129B in trailing free cash flow, and a $4.63T market cap trading at ~38x earnings, I upgrade AAPL to Buy and propose a mid-term swing trade to capture post-WWDC re-rating and continued iPh…
Nano Labs (NA) trades at a $59M market cap with a P/E of 2.84 and PB under 0.6 while sitting on strategic crypto reserves and new AI/edge hardware initiatives. The market has punished the name aggressively; we present a long trade for disciplined investors with an entry at $2.50, stop at $2.10 and a $4.50 target over a 180 trading-day horizon.
SAP's shares have retraced sharply from a $313 52-week high to the $190 area, but underlying momentum, a string of strategic AI and cloud moves, and rising short interest create a setup for a mid-term rebound. This trade idea lays out a concrete long entry at $191.00, a stop at $176.00 and a target at $240.00 over a mid-term (45 trading days) horiz…
Reckitt Benckiser (RBGPF) has tumbled roughly 30% from recent levels. Technical indicators are oversold and short-interest dynamics point to ongoing covering. We upgrade to a Buy on a mid-term swing basis with an entry at $60.01, a stop at $52.00 and a target of $75.00 over ~45 trading days.
Newmont is a high-quality, well-capitalized gold producer trading at a mid-teens P/E and single-digit EV/EBITDA amid elevated gold prices and renewed asset repricing. We present a staged long trade with concrete entry, stop and target levels across short, mid and long horizons.
Vistance Networks (VISN) is sitting on a compact, cash-rich balance sheet after the CCS divestiture and a material special distribution. The market currently prices the remaining business at EV/FCF ~1.3x and EV/EBITDA ~0.37x. If Aurora/Ruckus-like assets deserve anything near the 12-13x multiple paid by strategic buyers, VISN has meaningful upside.…
Capricor Therapeutics is a clinical-stage cell and exosome developer that has both a recent history of regulatory setbacks and a string of positive clinical/regulatory interactions. With a market cap of roughly $1.58B, a cash runway that looks meaningful on a go-forward basis, and elevated short interest, the stock is a high-volatility but asymmetr…
Advanced Micro Devices has moved from momentum trade to a fundamentally defensible buy. Strong AI-driven demand, improving technicals, large free cash flow, and a rock-solid balance sheet underpin a swing trade. Valuation is rich, so risk management is central: entry at $520, stop at $480, target $620 over the next 45 trading days.
Enterprise Products Partners (EPD) presents a compelling buy-the-pullback opportunity. The partnership trades at a modest P/E of ~13.8, yields ~5.9%, generates roughly $2.2B in free cash flow and sits on an $81.5B market cap. With pipeline “toll” economics and growing demand pressure on energy and petrochemical feedstocks from expanding AI datacent…
Microsoft's mix of recurring enterprise software, a dominant cloud franchise, and expanding AI platform products gives it outsized recession resilience. At roughly $3.28 trillion market cap, the stock still offers durable free cash flow, low leverage, and technical momentum. This trade idea lays out an entry, stop, and target for a long bias over a…
Salesforce has the balance sheet, cash flow and AI investments that should drive a bookings rebound in H2. Technical momentum and heavy short interest amplify upside in the near-to-mid term. We lay out a position trade with entry, stop and target and a timeline tied to H2 bookings cadence.
Innovative Solutions & Support (ISSC) doubled revenue in a recent quarter after acquiring Honeywell's F-16 product line. The market is focused on integration pain and a short-term pull-forward; we view this as an opportunity. With a $307M market cap, positive free cash flow and improving technicals, ISSC is a tactical long for a mid-term swing as M…
Rhythm (RYTM) is a commercial-stage rare-disease biotech with an FDA-approved MC4R agonist, IMCIVREE. Recent approvals and a busy June conference/data calendar make the stock a tactical long over the next 45 trading days. Valuation is rich, but near-term catalysts and improving commercial execution justify a mid-term swing trade with defined risk c…
Sterling Infrastructure sits squarely in the AI/data-center supply chain after a rapid re-rating. Strong top-line momentum, a $5.15B backlog and raised guidance argue for continued upside, but the stock trades at a steep multiple. This trade idea targets a mid-term swing entry on a controlled pullback with clear stop and target levels.
Applied Optoelectronics (AAOI) is benefiting from hyperscaler demand for 800G and 1.6T optical modules. Strong tape of volume, improving technicals and continued product-led scarcity support a tactical long. The valuation is rich, so keep position sizing prudent and use a clearly defined stop.
Nebius Group (NBIS) is trading after an all-time high on heavyweight endorsements and multibillion customer commitments. The company is executing an aggressive capacity build to capture AI cloud demand, and recent top-line momentum is explosive. This trade idea outlines a long-biased plan with entry, stop and target that balances the structural gro…
